Economic evaluations of treatment of depressive disorders in adolescents: Protocol for a scoping review.
adolescent
cost-benefit analysis
cost-effectiveness analysis
cost-utility analysis
depression
economic evaluation
scoping review
Journal
Early intervention in psychiatry
ISSN: 1751-7893
Titre abrégé: Early Interv Psychiatry
Pays: Australia
ID NLM: 101320027
Informations de publication
Date de publication:
07 Feb 2024
07 Feb 2024
Historique:
revised:
28
09
2023
received:
23
02
2023
accepted:
24
01
2024
medline:
7
2
2024
pubmed:
7
2
2024
entrez:
7
2
2024
Statut:
aheadofprint
Résumé
Depressive disorders in adolescents are common and impairing. Evidence-based treatments are available; however, at a cost. In the context of the COVID-19 pandemic, we anticipate increased demand for treatment services for adolescents with depression. We also anticipate that economic resources will be strained. Identifying cost-effective strategies to optimally treat depression in adolescents is imperative. This protocol for a scoping review aims to describe the literature with respect to economic evaluations of treatments for depression in adolescents. We will conduct a scoping review using established methods and reporting guidelines. MEDLINE, Embase, PsyclNFO, Econlit, and the International HTA Database will be searched from inception to June 13, 2023, with an update closer to time of manuscript submission, while the NHS Economic Evaluation Database archives will be searched from inception to December 2014. Publications that contain economic evaluations, in the context of a clinical trial or a model-based study, testing a treatment of depression in adolescents will be selected for inclusion. Extracted data items will include: economic evaluation perspectives, health outcome variables and costs used in economic evaluations, types of analyses performed, as well as quality of reporting and methodology. A narrative synthesis with summary tables will be used to describe our findings. Our findings will help identify gaps in the literature with respect to economic analyses for the treatment of depression such that these gaps can be filled with future research. Policy-makers, funders and administrators may also use our findings to inform their decisions around provision of various treatments for depression in adolescents. osf.io/5fteb (note that information on this link will be updated upon acceptance for publication based on reviewer comments).
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Cundill Centre for Child and Youth Depression
Organisme : Margaret and Wallace McCain Centre for Child, Youth, and Family Mental Health
Informations de copyright
© 2024 John Wiley & Sons Australia, Ltd.
Références
Avenevoli, S., Swendsen, J., He, J. P., Burstein, M., & Merikangas, K. R. (2015). Major depression in the national comorbidity survey-adolescent supplement: Prevalence, correlates, and treatment. Journal of the American Academy of Child and Adolescent Psychiatry, 54(1), 37-44.e2. https://doi.org/10.1016/j.jaac.2014.10.010
Bennett, K., Courtney, D., Duda, S., Henderson, J., & Szatmari, P. (2018). An appraisal of the trustworthiness of practice guidelines for depression and anxiety in children and youth. Depression and Anxiety, 35(6), 530-540.
Byford, S., Barrett, B., Roberts, C., Wilkinson, P., Dubicka, B., Kelvin, R. G., White, L., Ford, C., Breen, S., & Goodyer, I. (2007). Cost-effectiveness of selective serotonin reuptake inhibitors and routine specialist care with and without cognitive-behavioural therapy in adolescents with major depression. The British Journal of Psychiatry, 191(DEC), 521-527. https://doi.org/10.1192/bjp.bp.107.038984
Clayborne, Z. M., Varin, M., & Colman, I. (2018). Adolescent depression and long-term psychosocial outcomes: A systematic review and meta-analysis. Journal of the American Academy of Child and Adolescent Psychiatry, 58(1), 72-79. https://doi.org/10.1016/j.jaac.2018.07.896
Courtney, D. B., Watson, P., Chan, B. W. C., Bennett, K., Krause, K. R., Offringa, M., Butcher, N. J., Monga, S., Neprily, K., Zentner, T., Rodak, T., & Szatmari, P. (2021;(Online ahead of print):1-17.). Forks in the road: Definitions of response, remission, recovery and other dichotomized outcomes in randomized controlled trials for adolescent depression. A scoping review. Depression and Anxiety, 38, 1152-1168. https://doi.org/10.1002/da.23200
Cutler, D. M., & Summers, L. H. (2020). The COVID-19 pandemic and the $16 trillion virus. Journal of the American Medical Association, 324(15), 1495-1496.
de Oliveira, C., Cho, E., Kavelaars, R. A., Jamieson, M., Bao, B., & Rehm, J. (2020). Economic analyses of mental health and substance use interventions in the workplace: A systematic literature review and narrative synthesis. The Lancet Psychiatry, 7(10), 893-910. https://doi.org/10.1016/S2215-0366(20)30145-0
Domino, M. E., Burns, B. J., Silva, S. G., Kratochvil, C. J., Vitiello, B., Reinecke, M. A., Mario, J., & March, J. S. (2008). Cost-effectiveness of treatments for adolescent depression: Results from TADS. The American Journal of Psychiatry, 165(5), 588-596. https://doi.org/10.1176/appi.ajp.2008.07101610
El Alili, M., van Dongen, J. M., Esser, J. L., Heymans, M. W., van Tulder, M. W., & Bosmans, J. E. (2022). A scoping review of statistical methods for trial-based economic evaluations: The current state of play. Health Economics, 31(12), 2680-2699.
Fergusson, D. M., & Woodward, L. J. (2002). Mental health, educational, and social role outcomes of adolescents with depression. Archives of General Psychiatry, 59(3), 225-231. http://www.ncbi.nlm.nih.gov/pubmed/11879160
Fleiss, J. L., Levin, B., & Paik, M. C. (2013). Statistical methods for rates and proportions. John Wiley & Sons.
Gili, M., Castellví, P., Vives, M., de la Torre-Luque, A., Almenara, J., Blasco, M. J., Cebrià, A. I., Gabilondo, A., Pérez-Ara, M. A., Miranda-Mendizábal, A., Lagares, C., Parés-Badell, O., Piqueras, J. A., Rodríguez-Jiménez, T., Rodríguez-Marín, J., Soto-Sanz, V., Alonso, J., & Roca, M. (2019). Mental disorders as risk factors for suicidal behavior in young people: A meta-analysis and systematic review of longitudinal studies. Journal of Affective Disorders, 245(October 2018), 152-162. https://doi.org/10.1016/j.jad.2018.10.115
Gore, F. M., Bloem, P. J. N., Patton, G. C., Ferguson, J., Joseph, V., Coffey, C., Sawyer, S. M., & Mathers, C. D. (2011). Global burden of disease in young people aged 10-24 years: A systematic analysis. Lancet, 377(9783), 2093-2102. https://doi.org/10.1016/S0140-6736(11)60512-6
Heffernan, O. S., Herzog, T. M., Schiralli, J. E., Hawke, L. D., Chaim, G., & Henderson, J. L. (2017). Implementation of a youth-adult partnership model in youth mental health systems research: Challenges and successes. Health Expectations, 20(6), 1183-1188.
Husereau, D., Drummond, M., Augustovski, F., de Bekker-Grob, E., Briggs, A. H., Carswell, C., Caulley, L., Chaiyakunapruk, N., Greenberg, D., Loder, E., Mauskopf, J., Mullins, C. D., Petrou, S., Pwu, R. F., Staniszewska, S., & CHEERS 2022 ISPOR Good Research Practices Task Force. (2022). Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations. International Journal of Technology Assessment in Health Care, 38(1), e13.
Lee, K., McCarron, C., Stirling, B., Coyle, D., Krahn, M., & McCabe, C. (2017). Guidelines for the economic evaluation of health technologies: Canada 4th edition CADTH METHODS AND GUIDELINES service line: CADTH methods and guidelines. Vol 1.0. Ottawa, Ontario, Canada. https://www.cadth.ca/sites/default/files/pdf/guidelines_for_the_economic_evaluation_of_health_technologies_canada_4th_ed.pdf
Lynch, F. L., & Clarke, G. N. (2006). Estimating the economic burden of depression in children and adolescents. American Journal of Preventive Medicine, 31(6 SUPPL. 1), 143-151. https://doi.org/10.1016/j.amepre.2006.07.001
Mojtabai, R., Olfson, M., & Han, B. (2016). National trends in the prevalence and treatment of depression in adolescents and young adults. Pediatrics, 138(6), e20161878. https://doi.org/10.1542/peds.2016-1878
Mutubuki, E. N., El Alili, M., Bosmans, J. E., Oosterhuis, T. J., Snoek, F., Ostelo, R. W., Van Tulder, M. W., & Van Dongen, J. M. (2021). The statistical approach in trial-based economic evaluations matters: Get your statistics together! BMC Health Services Research, 21(1), 475.
NICE Depression in children and young people: identification and management. NICE guideline [NG134]. National Institute for Health and Care Excellence, 2019.
Ofman, J. J., Sullivan, S. D., Neumann, P. J., Chiou, C. F., Henning, J. M., Wade, S. W., & Hay, J. W. (2003). Examining the value and quality of health economic analyses: Implications of utilizing the QHES. Journal of Managed Care Pharmacy, 9(1), 53-61.
Page, M. J., McKenzie, J. E., Bossuyt, P. M., Boutron, I., Hoffmann, T. C., Mulrow, C. D., Shamseer, L., Tetzlaff, J. M., Akl, E. A., Brennan, S. E., Chou, R., Glanville, J., Grimshaw, J. M., Hróbjartsson, A., Lalu, M. M., Li, T., Loder, E. W., Mayo-Wilson, E., McDonald, S., … Moher, D. (2021). The PRISMA 2020 statement: An updated guideline for reporting systematic reviews. International Journal of Surgery, 88, 105906. https://doi.org/10.1016/j.ijsu.2021
Peters, M., Godfrey, C., McInerney, P., Munn, Z., Trico, A., & Khalil, H. (2020). JBI manual for evidence synthesis. In E. Aromataris & Z. Munn (Eds.), JBI manual for evidence synthesis. JBI. https://doi.org/10.46658/JBIMES-20-12
Pham, M. T., Rajić, A., Greig, J. D., Sargeant, J. M., Papadopoulos, A., & Mcewen, S. A. (2014). A scoping review of scoping reviews: Advancing the approach and enhancing the consistency. Research Synthesis Methods, 5(4), 371-385. https://doi.org/10.1002/jrsm.1123
Poznanski, E. O., Freeman, L. N., & Mokros, H. B. (1985). Children's depression rating scale, revised (CDRS-R). Psychological Bulletin, 21, 979-989.
Racine, N., McArthur, B. A., Cooke, J. E., Eirich, R., Zhu, J., & Madigan, S. (2021). Global prevalence of depressive and anxiety symptoms in children and adolescents during COVID-19: A meta-analysis. JAMA Pediatrics, 175(11), 1142-1150. https://doi.org/10.1001/jamapediatrics.2021.2482
Renaud, J., Berlim, M. T., McGirr, A., Tousignant, M., & Turecki, G. (2008). Current psychiatric morbidity, aggression/impulsivity, and personality dimensions in child and adolescent suicide: A case-control study. Journal of Affective Disorders, 105(1-3), 221-228. https://doi.org/10.1016/j.jad.2007.05.013
Sung, J. Y., Kacmarek, C. N., & Schleider, J. L. (2021). Economic evaluations of mental health programs for children and adolescents in the United States: A systematic review. Clinical Child and Family Psychology Review, 24, 1-9.
The Joanna Briggs Institute. (2014). The Joanna Briggs Institute Reviewers' Manual: 2014 edition. The Systematic Review of Economic Evaluation Evidence. jbi.global.
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., Hempel, S., Akl, E. A., Chang, C., McGowan, J., Stewart, L., Hartling, L., Aldcroft, A., Wilson, M. G., Garritty, C., … Straus, S. E. (2018). PRISMA extension for scoping reviews (PRISMA-ScR): Checklist and explanation. Annals of Internal Medicine, 169(7), 467-473.
Wright, D. R., Haaland, W. L., Ludman, E., McCauley, E., Lindenbaum, J., & Richardson, L. P. (2016). The costs and cost-effectiveness of collaborative care for adolescents with depression in primary care settings: A randomized clinical trial. JAMA Pediatrics, 170(11), 1048-1054. https://doi.org/10.1001/jamapediatrics.2016.1721